Hiroko Tomiyama
- Immunology top 2%
- Virology top 1%
- Molecular Biology
- Hematology top 2%
- Oncology top 10%
- Co-authors
- Masafumi TakiguchiTomoko MatsudaShinichi OkaMamoru FujiwaraHiroshi TakataYuji SobaoAikichi IwamotoRyu Nakamura
- Topics
- Immune Cell Function and Interaction (22 papers)T-cell and B-cell Immunology (21 papers)HIV Research and Treatment (17 papers)
- Cited by
- VirologyImmunologyHematology
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Hiroko Tomiyama
35 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Immunology 1.3k
- Virology 561
- Molecular Biology 543
- Hematology 462
- Oncology 434
Countries citing papers authored by Hiroko Tomiyama
This map shows the geographic impact of Hiroko Tomiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Tomiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Tomiyama more than expected).
Fields of papers citing papers by Hiroko Tomiyama
This network shows the impact of papers produced by Hiroko Tomiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Tomiyama. The network helps show where Hiroko Tomiyama may publish in the future.
Co-authorship network of co-authors of Hiroko Tomiyama
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Tomiyama. A scholar is included among the top collaborators of Hiroko Tomiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Tomiyama. Hiroko Tomiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal regionbreakdown → | 717 |
| 2 | 44 | |
| 3 | 70 | |
| 4 | 19 | |
| 5 | 14 | |
| 6 | 13 | |
| 7 | 189 | |
| 8 | 27 | |
| 9 | 63 | |
| 10 | 25 | |
| 11 | 52 | |
| 12 | 9 | |
| 13 | 33 | |
| 14 | 61 | |
| 15 | 10 | |
| 16 | 14 | |
| 17 | 10 | |
| 18 | 66 | |
| 19 | 1 | |
| 20 | 42 |
About Hiroko Tomiyama
Hiroko Tomiyama is a scholar working on Virology, Immunology and Hepatology, having authored 35 papers that have together received 2.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (22 papers), T-cell and B-cell Immunology (21 papers) and HIV Research and Treatment (17 papers). The work is most often cited by research in Virology (561 citations), Immunology (1.3k citations) and Hematology (462 citations). Hiroko Tomiyama has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Masafumi Takiguchi, Tomoko Matsuda, Shinichi Oka, Mamoru Fujiwara, Hiroshi Takata, Yuji Sobao, Aikichi Iwamoto, Ryu Nakamura, Shuichi Taniguchi and Toru Tanaka. Their work appears in journals such as Nature Biotechnology, The Journal of Immunology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.